Valuation check: CVET's profit margin is -0.28%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2022
Trailing 12 months ending Jun 2022
Covetrus (CVET) currently reports a profit margin of -0.28% as of June 2022. That compares with -1.89% in the prior-year period — up 85.2% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Covetrus's profit margin history and peer comparisons.
Covetrus's profit margin increased from -1.89% to -0.28% — a 85.2% year-over-year increase (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Covetrus's profit margin of -0.28% is lower than the Healthcare sector average of 13.89%. That is roughly 102.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Covetrus's current -0.28% should be judged against Healthcare norms (sector average: 13.89%) and against CVET's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -0.28%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Covetrus, and consider following CVET for alerts when major investors trade the stock.